CONTEXT: Polycystic ovary syndrome (PCOS) affects 5-8% of fertile women and is often accompanied by insulin resistance, leading to increased risk of developing type 2 diabetes. Skeletal muscle from insulin-resistant PCOS subjects display reduced expression of nuclear encoded genes involved in mitochondrial oxidative metabolism. OBJECTIVE: We aimed to investigate whether there was a primary mitochondrial dysfunction or difference in mitochondria content that might contribute to the in vivo detected insulin resistance. DESIGN: The ATP synthesis with and without ATP use and the mitochondrial mass was determined in mitochondria isolated from myotubes established from PCOS subjects and control subjects. PATIENTS: Myotubes were established from eight insulin-resistant PCOS subjects (verified by euglycemic hyperinsulinemic clamp) and eight healthy weight- and age-matched controls. RESULTS:Mitochondrial mass and measurable mitochondrial ATP synthesis, with and without ATP use, were not different between PCOS subjects and control subjects. CONCLUSION: We found no evidence for a primary impaired mitochondrial function or content in myotubes established from PCOS subjects, and our results suggest that reduced expression of oxidative genes in PCOS subjects is an adaptive trait.
RCT Entities:
CONTEXT: Polycystic ovary syndrome (PCOS) affects 5-8% of fertile women and is often accompanied by insulin resistance, leading to increased risk of developing type 2 diabetes. Skeletal muscle from insulin-resistant PCOS subjects display reduced expression of nuclear encoded genes involved in mitochondrial oxidative metabolism. OBJECTIVE: We aimed to investigate whether there was a primary mitochondrial dysfunction or difference in mitochondria content that might contribute to the in vivo detected insulin resistance. DESIGN: The ATP synthesis with and without ATP use and the mitochondrial mass was determined in mitochondria isolated from myotubes established from PCOS subjects and control subjects. PATIENTS: Myotubes were established from eight insulin-resistant PCOS subjects (verified by euglycemic hyperinsulinemic clamp) and eight healthy weight- and age-matched controls. RESULTS: Mitochondrial mass and measurable mitochondrial ATP synthesis, with and without ATP use, were not different between PCOS subjects and control subjects. CONCLUSION: We found no evidence for a primary impaired mitochondrial function or content in myotubes established from PCOS subjects, and our results suggest that reduced expression of oxidative genes in PCOS subjects is an adaptive trait.
Authors: Melanie Cree-Green; Bradley R Newcomer; Gregory Coe; Lindsey Newnes; Amy Baumgartner; Mark S Brown; Laura Pyle; Jane E Reusch; Kristen J Nadeau Journal: Am J Physiol Endocrinol Metab Date: 2015-02-24 Impact factor: 4.310
Authors: Muraly Puttabyatappa; Joseph N Ciarelli; Adam G Chatoff; Vasantha Padmanabhan Journal: Mol Cell Endocrinol Date: 2021-02-17 Impact factor: 4.102
Authors: Adam R Konopka; Albert Asante; Ian R Lanza; Matthew M Robinson; Matthew L Johnson; Chiara Dalla Man; Claudio Cobelli; Mark H Amols; Brian A Irving; K S Nair Journal: Diabetes Date: 2015-01-20 Impact factor: 9.461
Authors: Alba Moreno-Asso; Ali Altıntaş; Luke C McIlvenna; Rhiannon K Patten; Javier Botella; Andrew J McAinch; Raymond J Rodgers; Romain Barrès; Nigel K Stepto Journal: J Mol Endocrinol Date: 2021-12-03 Impact factor: 5.098
Authors: Luke C McIlvenna; Rhiannon K Patten; Andrew J McAinch; Raymond J Rodgers; Nigel K Stepto; Alba Moreno-Asso Journal: Front Endocrinol (Lausanne) Date: 2021-10-11 Impact factor: 5.555
Authors: Mette B Eriksen; Michael F B Nielsen; Klaus Brusgaard; Qihua Tan; Marianne S Andersen; Dorte Glintborg; Michael Gaster Journal: PLoS One Date: 2013-09-27 Impact factor: 3.240
Authors: Antti-Pekka E Rissanen; Tiina Koskela-Koivisto; Harriet Hägglund; Anne S Koponen; Jyrki M Aho; Maritta Pöyhönen-Alho; Aila Tiitinen; Heikki O Tikkanen; Juha E Peltonen Journal: Physiol Rep Date: 2016-02